Paroxysmal AV block Laboratory Findings and Stimulation tests: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
==Overview== | |||
Adenosine Plasma levels, adenosine triphosphate stimulation tests and lab values related to potential reversible causes of AV block such as a thyroid profile, electrolyte values,etc are important laboratory investigations. | |||
=Laboratory Investigations and stimulation tests= | =Laboratory Investigations and stimulation tests= | ||
*'''Adenosine plasma levels (APL) and Adneosine Triphosphate (ATP)stimulation tests are tests of value in extrinsic idiopathic AV Block'''. | *'''Adenosine plasma levels (APL) and Adneosine Triphosphate (ATP)stimulation tests are tests of value in extrinsic idiopathic AV Block'''. | ||
| Line 13: | Line 16: | ||
for a potential underlying cause are reasonable ''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C-LD]])<ref name="pmid30412710">{{cite journal| author=Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR | display-authors=etal| title=2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. | journal=J Am Coll Cardiol | year= 2019 | volume= 74 | issue= 7 | pages= 932-987 | pmid=30412710 | doi=10.1016/j.jacc.2018.10.043 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30412710 }} </ref>'' <nowiki>"</nowiki> | for a potential underlying cause are reasonable ''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C-LD]])<ref name="pmid30412710">{{cite journal| author=Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR | display-authors=etal| title=2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. | journal=J Am Coll Cardiol | year= 2019 | volume= 74 | issue= 7 | pages= 932-987 | pmid=30412710 | doi=10.1016/j.jacc.2018.10.043 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30412710 }} </ref>'' <nowiki>"</nowiki> | ||
|} | |} | ||
==References== | |||
Revision as of 22:00, 27 June 2020
Overview
Adenosine Plasma levels, adenosine triphosphate stimulation tests and lab values related to potential reversible causes of AV block such as a thyroid profile, electrolyte values,etc are important laboratory investigations.
Laboratory Investigations and stimulation tests
- Adenosine plasma levels (APL) and Adneosine Triphosphate (ATP)stimulation tests are tests of value in extrinsic idiopathic AV Block.
- As previously discussed, APL levels are innately low in patients with EI AVB and therefore, on injection of ATP, AV blocks maybe reproduced.
- Other lab investigations such as arterial blood gas analysis, hemoglobin, troponin or D- dimer may help with the diagnoses in appropriate clinical situations. "ESC Guidelines on Syncope (Diagnosis and Management of)".
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Recommendation for Laboratory Testing
| Recommendation for Laboratory Testing |
| "1. In patients with bradycardia, laboratory tests (eg, thyroid function tests, Lyme titer, potassium, pH) based on clinical suspicion
for a potential underlying cause are reasonable (Level of Evidence: C-LD)[1] " |
References
- ↑ Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR; et al. (2019). "2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society". J Am Coll Cardiol. 74 (7): 932–987. doi:10.1016/j.jacc.2018.10.043. PMID 30412710.